HIV Treatment, Antiretroviral Adherence and AIDS Mortality in People Who Inject Drugs: a Scoping Review

Overview

Journal Eur J Public Health

Publisher Oxford University Press

Specialty Public Health

Date 2023 Feb 1

PMID 36723859

Authors

Anneli Uuskula

Jonathan Feelemyer

Don C Des Jarlais

Affiliations

Soon will be listed here.

Abstract

Background: People who inject drugs (PWID) are a key population for the prevention and care of HIV infection.

Methods: This scoping review covers recent (post-2010) systematic reviews on engagement of PWID in sequential stages of HIV care from uptake, to achieving viral suppression, and to avoiding AIDS-related mortality.

Results: We found that data on engagement of PWID into antiretroviral therapy (ART) were particularly scarce, but generally indicated very low engagement in ART. Studies of adherence and achieving viral suppression showed varying results, with PWID sometimes doing as well as other patient groups. The severity of social, medical and psychiatric disability in this population poses significant treatment challenges and leads to a marked gap in AIDS mortality between PWID and other population groups.

Conclusions: Given the multi-level barriers, it will be difficult to reach current targets (UNAIDS fast-track targets of 95-95-95) for ART for PWID in many locations. We suggest giving priority to reducing the likelihood that HIV seropositive PWID will transmit HIV to others and reducing morbidity and mortality from HIV infection and from other comorbidities.

Citing Articles

Prevalence and predictors of condom use among people who inject drugs in Georgia.

Kajaia M, Butsashvili M, DeHovitz J, Kamkamidze G, Gulbiani L, Abzianidze T Harm Reduct J. 2025; 22(1):21.

PMID: 39979984 PMC: 11844099. DOI: 10.1186/s12954-025-01171-6.

HCV Treatment Outcomes in PWID: Impact of Addiction History on SVR12.

Milosevic I, Beronja B, Filipovic A, Mitrovic N, Simic J, Knezevic N Microorganisms. 2025; 12(12.

PMID: 39770757 PMC: 11677223. DOI: 10.3390/microorganisms12122554.

Rising mortality among people who inject drugs living with HIV in Scotland, UK: A 20-year retrospective cohort study.

Metcalfe R, Fraser R, Trayner K, Glancy M, Yeung A, Sills L HIV Med. 2024; 26(2):265-274.

PMID: 39557520 PMC: 11786617. DOI: 10.1111/hiv.13733.

Telehealth to increase healthcare access; perspectives of people who use drugs.

Papalamprakopoulou Z, Ntagianta E, Triantafyllou V, Kalamitsis G, Dharia A, Dickerson S BMC Med Inform Decis Mak. 2024; 24(1):306.

PMID: 39425182 PMC: 11490127. DOI: 10.1186/s12911-024-02718-6.

Risky sexual practice and associated factors among adult people living with HIV/AIDS in public hospitals of Kembata Tambaro Zone, Southern Ethiopia: a cross-sectional study.

Bekele Z, Mussa I, Assefa Y, Abera N, Amerga E, Girma A BMJ Open. 2023; 13(7):e072505.

PMID: 37463817 PMC: 10357730. DOI: 10.1136/bmjopen-2023-072505.

References

Seckinelgin H . : The life of the HIV care cascade as an international AIDS policy and its implications. Glob Public Health. 2019; 15(3):321-333. DOI: 10.1080/17441692.2019.1673784. View

Des Jarlais D, Huong D, Oanh K, Pham M, Thi Giang H, Tuyet Thanh N . Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam. Int J Drug Policy. 2016; 32:50-6. PMC: 4899107. DOI: 10.1016/j.drugpo.2016.02.021. View

Baral S, Rao A, Sullivan P, Phaswana-Mafuya N, Diouf D, Millett G . The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment. Lancet HIV. 2019; 6(9):e632-e638. DOI: 10.1016/S2352-3018(19)30226-7. View

Park L, Tate J, Sigel K, Brown S, Crothers K, Gibert C . Association of Viral Suppression With Lower AIDS-Defining and Non-AIDS-Defining Cancer Incidence in HIV-Infected Veterans: A Prospective Cohort Study. Ann Intern Med. 2018; 169(2):87-96. PMC: 6825799. DOI: 10.7326/M16-2094. View

Cohen M . Successful treatment of HIV eliminates sexual transmission. Lancet. 2019; 393(10189):2366-2367. DOI: 10.1016/S0140-6736(19)30701-9. View

Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E . Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016; 139:3-12. DOI: 10.1016/j.puhe.2016.05.004. View

Bazzi A, Drainoni M, Biancarelli D, Hartman J, Mimiaga M, Mayer K . Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019; 19(1):31. PMC: 6323713. DOI: 10.1186/s12889-018-6314-8. View

Croxford S, Kitching A, Desai S, Kall M, Edelstein M, Skingsley A . Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort. Lancet Public Health. 2017; 2(1):e35-e46. DOI: 10.1016/S2468-2667(16)30020-2. View

Pham Q, Wilson D, Law M, Kelleher A, Zhang L . Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis. AIDS. 2014; 28(18):2751-62. DOI: 10.1097/QAD.0000000000000494. View

10.

Mills E, Nachega J, Buchan I, Orbinski J, Attaran A, Singh S . Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA. 2006; 296(6):679-90. DOI: 10.1001/jama.296.6.679. View

11.

Des Jarlais D, Kerr T, Carrieri P, Feelemyer J, Arasteh K . HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks. AIDS. 2016; 30(6):815-26. PMC: 4785082. DOI: 10.1097/QAD.0000000000001039. View

12.

Katz I, Maughan-Brown B . Improved life expectancy of people living with HIV: who is left behind?. Lancet HIV. 2017; 4(8):e324-e326. PMC: 5828160. DOI: 10.1016/S2352-3018(17)30086-3. View

13.

Glick J, Huang A, Russo R, Jivapong B, Ramasamy V, Rosman L . ART uptake and adherence among women who use drugs globally: A scoping review. Drug Alcohol Depend. 2020; 215:108218. PMC: 7899784. DOI: 10.1016/j.drugalcdep.2020.108218. View

14.

McNamara K, Biondi B, Hernandez-Ramirez R, Taweh N, Grimshaw A, Springer S . A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease Outcomes. Open Forum Infect Dis. 2021; 8(8):ofab289. PMC: 8378589. DOI: 10.1093/ofid/ofab289. View

15.

Mathers B, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M . Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013; 91(2):102-23. PMC: 3605003. DOI: 10.2471/BLT.12.108282. View

16.

Munn Z, Peters M, Stern C, Tufanaru C, McArthur A, Aromataris E . Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018; 18(1):143. PMC: 6245623. DOI: 10.1186/s12874-018-0611-x. View

17.

Werb D, Mills E, Montaner J, Wood E . Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis. Lancet Infect Dis. 2010; 10(7):464-9. DOI: 10.1016/S1473-3099(10)70097-9. View

18.

Ehrenkranz P, Rosen S, Boulle A, Eaton J, Ford N, Fox M . The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals. PLoS Med. 2021; 18(5):e1003651. PMC: 8186775. DOI: 10.1371/journal.pmed.1003651. View

19.

Parashar S, Collins A, Montaner J, Hogg R, Milloy M . Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs. Curr Opin HIV AIDS. 2016; 11(5):507-513. PMC: 5055433. DOI: 10.1097/COH.0000000000000297. View

20.

Des Jarlais D, Sypsa V, Feelemyer J, Abagiu A, Arendt V, Broz D . HIV outbreaks among people who inject drugs in Europe, North America, and Israel. Lancet HIV. 2020; 7(6):e434-e442. PMC: 10150936. DOI: 10.1016/S2352-3018(20)30082-5. View